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A B S T R A C T
Background
Cartilage defects of the knee are often debilitating and predispose to osteoarthritis. Microfracture, drilling, mosaicplasty, and allograft
transplantation are four surgical treatment options that are increasingly performed worldwide. We set out to examine the relative effects
of these different methods.
Objectives
To assess the relative effects (benefits and harms) of different surgical interventions (microfracture, drilling, mosaicplasty, and allograft
transplantation) for treating isolated cartilage defects of the knee in adults.
Search methods
We searched the Cochrane Bone, Joint and Muscle Trauma Group Specialised Register, CENTRAL, EMBASE, MEDLINE, SPORT-
Discus, LILACS, trial registers and conference proceedings up to February 2016.
Selection criteria
Any randomised or quasi-randomised trials that evaluated surgical interventions (microfracture, drilling, mosaicplasty, and allograft
transplantation) for treating isolated cartilage defects of the knee in adults.
Data collection and analysis
At least two review authors independently selected studies, assessed risk of bias and extracted data. Intervention effects were assessed
using risk ratios (RR) for dichotomous data and mean differences (MD) for continuous data, with 95% confidence intervals (CI). Data
were pooled using the fixed-effect model, where possible.
Main results
We included three randomised controlled trials comparing mosaicplasty versus microfracture for isolated cartilage defects in adults.
Two trials were single-centre trials and one involved three centres. These small trials reported results for a total of 133 participants, of
whom 79 (59%) were male. Mean participant age in the three trials ranged from 24.4 years to 32.3 years. All studies included grade
1Surgical interventions (microfracture, drilling, mosaicplasty, and allograft transplantation) for treating isolated cartilage defects of the
knee in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
3 or 4 cartilage lesions (International Cartilage Repair Society (ICRS) classification). The defect area ranged from 1.0 cm² to 6.0 cm²;
the mean area in all three trials was 2.8 cm². No trials of allograft transplantation or drilling were identified.
All trials were judged as being at high or unclear risk of performance and reporting bias. We judged that the quality of evidence was
very low for all outcomes. For individual outcomes, we downgraded the quality of evidence by one or two levels for risk of bias, one
level for indirectness where there were data from a single-centre trial only, one or two levels for imprecision where there were wide
confidence intervals and an insufficient number of events, and one level for inconsistency reflecting heterogeneity. This means that we
are very uncertain about the estimates for all outcomes.
There is very low quality evidence from one single-centre trial (57 participants), which included athletes only, that mosaicplasty resulted
in higher patient-reported function scores (probably the IKDC 2000 subjective knee evaluation score) compared with microfracture
(range 0 to 100; higher score = better function) at one year follow-up (MD 10.29 favouring mosaicplasty, 95% CI 7.87 to 12.71).
Very low quality evidence from the same trial showed that this effect persisted in the long term at 10 years follow-up. However, there
is very low quality evidence from the two other trials (72 participants) of little difference in patient-reported function, assessed via the
Lysholm score (range 0 to 100; higher score = better function), between the two groups at long-term follow-up (MD -1.10 favouring
microfracture, 95%CI -4.54 to 2.33). One trial (25 participants) provided very low quality evidence of no significant difference between
the two groups in quality of life or pain at long-term follow-up. Pooled results for treatment failure - primarily symptom recurrence -
reported at long-term follow-up (means ranging from 6.3 to 1.4 years) in the three trials (129 participants) favoured mosaicplasty (10/
64 versus 20/65; RR 0.47, 95% CI 0.24 to 0.90). Based on an illustrative risk of 379 treatment failures per 1000 patients treated with
microfracture, there is very low quality evidence that 201 fewer patients (95% CI 38 to 288 fewer) would have treatment failure after
mosaicplasty. All three trials reported activity scores but due to clear statistical and clinical heterogeneity, we did not pool the long term
Tegner score results. There was very low quality evidence from one study (57 participants) of higher Tegner scores - indicating greater
activity - at intermediate-term and long-term follow-up in the mosaicplasty group; however, the between-group difference may not be
clinically important. The other two trials provided very low quality evidence of no significant difference between the two groups in
activity scores.
Authors’ conclusions
We found no evidence from randomised controlled trials on allograft transplantation or drilling. The very low quality evidence from
RCTs comparing mosaicplasty with microfracture is insufficient to draw conclusions on the relative effects of these two interventions
for treating isolated cartilage defects of the knee in adults. Of note is that treatment failure, with recurrence of symptoms, occurred
with both procedures. Further research is needed to define the best surgical option for treating isolated cartilage defects. We suggest
the greatest need is for multi-centre RCTs comparing reconstructive procedures (mosaicplasty versus allograft transplantation) for large
osteochondral lesions and reparative procedures (microfracture versus drilling) for small chondral lesions.
P L A I N L A N G U A G E S U M M A R Y
Surgical treatment options (microfracture, drilling, mosaicplasty, and allograft transplantation) for cartilage injuries of the
knee in adults
What is the medical problem?
The layer of cartilage covering the knee joint surfaces helps protect the joint and reduce friction during movement. Cartilage injuries of
the knee in adults can result from trauma, such as during sport, or from a cartilage disease (osteochondritis). If left untreated, cartilage
injuries do not mend by themselves and can lead to significant destruction of the joint (osteoarthritis).
What treatments are available?
A number of treatment options are available for cartilage injuries but are often aimed at treating symptoms such as pain rather than
providing a cure.Non-surgical methods, such as physical therapy,may relieve symptoms but cannot heal cartilage injuries.Microfracture,
drilling, mosaicplasty, and allograft transplantation are increasingly available surgical treatments that attempt to preserve the joint.
What are microfracture, drilling, mosaicplasty, and allograft transplantation?
Microfracture and drilling are minimally invasive surgeries (key hole surgery) that promote bleeding from the bone to create a clot in the
cartilage defect. This can then form a tissue similar to cartilage. Mosaicplasty is an osteochondral transplant in which tissue is harvested
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from a less-demanding area of the knee to cover a cartilage defect in a more important area. Allograft transplantation treatment uses
tissue harvested from fresh cadavers to cover only the injured area.
Which of these surgical techniques works better in practice?
This review examines the evidence from randomised controlled trials that compared two or more of these surgical methods in clinical
practice.
We searched a number of medical databases up to February 2016 and found three studies that compared mosaicplasty versus microfrac-
ture. These studies reported results for a total of 133 participants, the majority of whom were young adults and male. No trials of
allograft transplantation or drilling were identified.
One study conducted at a single centre found better patient-reported function after mosaicplasty at 1, 2, 3, and 10 years follow-up.
However, the other studies did not find a difference in function (two studies), pain (one study) or activities of daily living (one study)
between mosaicplasty and microfracture in the long term (6 to 10 years follow-up). Treatment failure, with recurrence of symptoms,
occurred with both procedures. Data pooled from the three trials showed half as many people had treatment failure in the mosaicplasty
group. However, more evidence is required to test whether this is a true finding. The evidence regarding activity levels in the long term
was inconclusive.
We considered that all the evidence for these outcomes was very low quality. This means that we are unsure of these results, which are
likely to change when more evidence becomes available.
Conclusions
The currently available evidence is not enough to conclude whether mosaicplasty or microfracture is better for treating isolated cartilage
defects of the knee in adults. Treatment failure occurred with both methods. Further research is needed to define the best surgical
option for treating isolated cartilage defects.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Mosaicplasty compared with microfracture for adults with isolated cartilage defects of the knee
Patient or population: Adults with isolated cart ilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
Settings: Hospital
Intervention: Mosaicplasty (arthroscopic in two trials: defect area 1.0 cm2 to 4.0 cm2; m ini-invasive arthrotomy in one trial: defect area 2.0 cm2 to 6.0 cm2)
Comparison: Microf racture (all arthroscopic)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
M icrofracture Mosaicplasty
Function (all scores/ in-
struments): intermedi-
ate term
IKDC 2000 (version)
score. Scale f rom: 0 to
100; higher scores =
better funct ion.
Follow-up: 1 year
The mean funct ion
(IKDC score): interme-
diate term in the mi-
crof racture group was
75.59 points
The mean funct ion
(IKDC score): interme-
diate term in the mo-
saicplasty group was
10.29 higher
(7.87 to 12.71 higher)
MD 10.29 (7.87 to 12.
71)
57
(1 study)
⊕©©©
very low1
This single-
centre study included
athletes only. The clini-
cal importance of a 10
point dif f erence in IKDC
scores has not been es-
tablished. The trial re-
ports referred to these
as ‘‘ICRS scores’’
Function (all scores/ in-
struments): long term
Scale f rom: 0 to 100;
higher scores = better
funct ion.
Follow-up: 5 or more
years
The mean funct ion
(Lysholm score) ranged
across microf racture
groups f rom
69.7 to 85.6 points
The mean funct ion
(Lysholm score): long
term in the mosaic-
plasty groups was
1.1 lower
(4.54 lower to 2.33
higher)
MD -1.10 (-4.54 to 2.33) 72
(2 studies)
⊕©©©
very low2
Three studies ex-
pressed funct ion as ei-
ther Lysholm or ICRS
scores. However, the
studies were not pooled
because of substant ial
heterogeneity
It is unlikely that the
95% CI for the Lysholm
scores includes a clin-
ically important dif -
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f erence. The clinical
importance of a 14
point dif f erence in IKDC
scores has not been es-
tablished
The mean funct ion
(IKDC score) in the mi-
crof racture group
was
76.42 points
The mean funct ion
(IKDC score): long term
in the mosaicplasty
group was
13.97 higher
(13.25 to 14.69 higher)
MD 13.97 (13.25 to 14.
69)
57
(1 study)
⊕©©©
very low1
Quality of life: long-
term
KOOS QOL score. Scale
0 to 100; higher scores
= better QOL
Follow-up: 9.8 years
The mean KOOS QOL
score in the microf rac-
ture group was 59.7
points
The mean KOOS QOL
score in the mosaic-
plasty group was 7.00
lower (25.23 lower to
11.23 higher)
MD -7.00 (-25.23 to 11.
23)
25
(1 study)
⊕©©©
very low3
Failure of treatment
and adverse effects:
long- term
Part ic-
ipants with surgery and
symptom recurrence
Follow-up: 5 or more
years
379 per 10004 178 per 1000
(91 to 341)
RR 0.47
(0.24 to 0.9)
129
(3 studies)
⊕©©©
very low5
Pain: long- term
KOOS Pain score. Scale
0 to 100; higher scores
= less pain
Follow-up: 9.8 years
The mean KOOS Pain
score in the microf rac-
ture group was 73.4
points
The mean KOOS Pain
score in the mosaic-
plasty group was 7.50
lower (26.06 lower to
11.06 higher)
MD -7.50 (-26.06 to 11.
06)
25
(1 study)
⊕©©©
very low3
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Activity: intermediate
term (1 to 5 years fol-
low-up)
Tegner Score. Scale
f rom: 0 to 10; higher
scores = better act ivity.
Follow-up: mean 3
years
The mean act ivity: in-
termediate term (1 to
5 years follow-up) in
the microf racture group
was
6.88 points
The mean act ivity: in-
termediate term (1 to
5 years follow-up) in
the mosaicplasty group
was
0.48 higher
(0.21 to 0.75 higher)
MD 0.48 (0.21 to 0.75) 57
(1 study)
⊕©©©
very low1
Activity: long term (5
or more years follow-
up)
Tegner Score. Scale
f rom: 0 to 10; higher
scores = better act ivity.
Follow-up: mean 6.3 to
10.4 years
The mean act ivity: long
term (5 or more years
follow-up) in the three
microf racture groups
was 4.18, 5.1, and 6.14
points
The mean act ivity: long
term (5 or more years
follow-up) in the three
mosaicplasty groups
was
1.04 lower
(2.56 lower to 0.48
higher);
0.20 higher
(0.57 lower to 0.97
higher);
0.72 higher
(0.46 higher to 0.98
higher)
Results f rom 3 trials:
MD -1.04 (-2.56 to 0.48)
;
MD 0.20 (-0.57 to 0.97)
;
MD 0.72 (0.46 to 0.98)
25
(1 study)
47
(1 study)
57
(1 study)
⊕©©©
very low6
Results were not pooled
and these data mainly
serve to illustrate the
heterogeneity in the
longer term f inding of
the three trials
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95%CI) is based on the assumed
risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; ICRS: Internat ional Cart ilage Repair Society; IKDC: Internat ional Knee Documentat ion Committee; KOOS: Knee Injury and Osteoarthrit is Outcome Score;
MD: mean dif ference; QOL: quality of lif e; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 Downgraded three levels: one level for serious lim itat ions due to risk of bias (insuf f icient information about sequence
generat ion and allocat ion concealment, lack of blinding of surgeons, possible select ive report ing); one level for indirectness
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(single centre trial; athletes only); one level for serious inconsistency due to substant ial variat ion in ef fect est imate and
95% CI when considered alongside other studies report ing long term follow-up data on sim ilar outcome.
2 Downgraded three levels: two levels for very serious lim itat ions due to high risk of bias (including lack of allocat ion
concealment, lack of blinding of outcome assessment, select ive report ing bias); one level for serious imprecision due to small
sample size (n = 72); and one level for serious inconsistency due to substant ial variat ion in ef fect est imate and 95%CI across
all studies report ing long term follow-up data.
3 Downgraded three levels: two levels for very serious lim itat ions due to high risk of bias (especially lack of allocat ion
concealment) and two levels for very serious imprecision: wide conf idence interval and contribut ions f rom only 25 part icipants
of one trial.
4 Assumed risk for m icrof racture was based on the median control group risk across studies.
5 Downgraded three levels: two levels for very serious lim itat ions due to high risk of bias (including lack of allocat ion
concealment, lack of blinding of outcome assessment, select ive report ing bias); and one level for serious imprecision due to
low number of events (30)
6 Downgraded three levels: very serious lim itat ions due to risk of bias (insuf f icient information about sequence generat ion
and allocat ion concealment; lack of blinding of pat ients, personnel, and outcome assessors); serious inconsistency due to
substant ial variat ion in ef fect est imate (pooled data: I2 = 68.2%)
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B A C K G R O U N D
Description of the condition
Hyaline articular cartilage is a specialised tissue present in synovial
joints, such as the knee. It functions as a low-friction articulating
surface allowing joint motion and loading. Hyaline cartilage is
composed of collagen, noncollagenous proteins, water, and chon-
drocytes (cells). Cartilage is avascular and aneural, deriving nutri-
tion from synovial fluid through diffusion and from the subchon-
dral bone (Buckwalter 1990; Buckwalter 1992). Hyaline cartilage
has a poor repair capacity due to poor vascularity, the inability of
chondrocytes to multiply, and the low concentration of chondro-
cytes in the cartilage tissue. Therefore, injury or damage to car-
tilage tissue can lead to significant detrimental consequences for
the joint and the individual.
Cartilage injuries affect people of all ages. It is estimated that
900,000 people per year develop cartilage disease in the United
States alone (Mithoefer 2009). The prevalence in the population
who are athletes is 36% higher than in the normal population
(Flanigan 2010). Cartilage injuries are detected in up to 60% of
knee arthroscopies (Widuchowski 2007). The natural history of a
knee with cartilage injury is poorly understood but evidence sug-
gests that progression of cartilage injury to frank osteoarthritis is
common (Davies-Tuck 2008).
Cartilage injuries are commonly associated with symptoms such
as pain, joint locking, articular effusion, and crepitus (Brittberg
1994). Diagnosis can be made by magnetic resonance imaging
(MRI) and arthroscopy. Knee cartilage lesions represent a potential
threat to joint viability.
Description of the intervention
Several treatment methods for chondral injuries of the knee are
cited in the literature. Conservative treatment manages to achieve
symptom relief in some low-demand patients. Current surgical
treatment options for symptomatic patients include reparative and
reconstructive procedures. Reparative procedures involve tech-
niques that aim to stimulate patients’ cells to form hyaline carti-
lage-like tissue; a period of tissue maturation is expected. Recon-
structive procedures involve techniques that transplant autografts
or allografts with mature hyaline cartilage with the subchondral
bone attached. Bone consolidation is expected and no graft mat-
uration is necessary.
Reparative procedures for knee cartilage injury include microfrac-
ture (MF), abrasion arthroplasty, drilling, and ’biological proce-
dures’ involving cell culture (Johnson 2001; Lijoi 2001;Mithoefer
2006; Pridie 1959; Strauss 2009). The primary goal of MF and
abrasion arthroplasty is to promote bleeding from the subchondral
bone to create a blood clot at the lesion site, which thenmay differ-
entiate into fibrocartilage tissue. The microfracture technique in-
volves the use of an arthroscopic awl that is advanced manually to
make holes in the subchondral bone with depths of 2mm to 4mm
and separated 3 mm to 4 mm apart. The drilling technique uses
the same principal, instead with motorized drills to make holes in
the subchondral plate. The arthroscopic awls seem to not produce
thermal necrosis of the bone compared with motorized drills; this
could influence the bleeding needed for the subchondral bone and
clot formation.The abrasion arthroplasty technique is based on the
removal of a superficial layer of subchondral bone, 1 mm to 3 mm
thick, with motorized instruments to expose interosseous vessels
for possible fibrocartilage formation. Although fibrocartilage tis-
sue has different biological, structural, and mechanical properties
compared with the originally intact hyaline cartilage (Kaul 2012),
clinical improvement is nonetheless observed in many patients
(Gobbi 2005; Kreuz 2006; Mithoefer 2009; Steadman 2003).
Biological procedures are modern reparative procedures based on
the advancements of regenerative medicine, represented by differ-
ent generations of autologous chondrocyte implantation (ACI).
Chondrocyte implantation is a two-stage procedure. The first stage
consists of harvesting cartilage tissue during arthroscopy, which
is then processed in the laboratory to aseptically isolate chon-
drocytes and expand their numbers under closely-regulated cell
culture conditions. The second stage involves surgical implanta-
tion of the chondrocytes into the knee under a periosteal patch
(Brittberg 1994; Mithofer 2005; Peterson 2010). Second-genera-
tion ACI techniques introduced cell carriers for cell stabilisation
(Bartlett 2005), and third-generation approaches employ three-
dimensional biocompatible scaffolds to house the transplanted
chondrocytes (Marcacci 2005). These techniques, many of which
remain in early developmental stages and require further research
before they can be applied clinically, are not covered in this review
(Bonzani 2006; Nukavarapu 2013; Vasiliadis 2010b).
Reconstructive procedures available for treating knee cartilage in-
juries are mosaicplasty (osteochondral autograft transplantation)
and allograft transplantation. These are implantations of well-
formed osteochondral tissue (unit of osteochondral plugs or con-
structs), and no regeneration of cartilage is necessary (Ghazavi
2007; Gracitelli 2015; Hangody 1998).
Mosaicplasty, or osteochondral autograft transplantation, involves
excising round plugs of cartilage and underlying bone from non-
weight bearing areas of the femur, such as the intercondylar notch,
medial trochlea, and the lateral trochlea near the sulcus terminalis,
for transplantation; plugs for transplantation are usually taken
from the injured knee but can be harvested from the contralateral
knee if the injured area is particularly extensive (Hangody 1998).
Usually, several round plugs are necessary which, when inserted
into drilled holes of the injured knee joint surface, form a mosaic
pattern. The space between the plugs ultimately fills with newly-
formed fibrocartilage (Hangody 2008; Solheim 2010).
Allograft transplantation is another type of transplant using fresh
osteochondral plugs taken from cadaveric donors. The primary
advantage is there is no restriction on the size or number of plugs
that can be harvested from the donor knee, both of which are
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limited in autologous mosaicplasty (Bugbee 2012; Gross 1975).
Thus, osteochondral allograft plugs are more useful for treating
larger chondral or osteochondral lesions with areas larger than 2
cm2 that may occur with trauma, osteonecrosis, and osteochon-
dritis dissecans (Bugbee 2002; Krych 2012). Generally, the donor
is screened for viral and bacterial infectious diseases. This delays
transplantation by 10 to 14 days, during which time the endoge-
nous chondrocyte viability decreases. However, chondrocyte via-
bility can be preserved for longer times with adequate solutions
and temperature control in laboratory studies (Stoker 2012).
How the intervention might work
The reparative procedures (microfracture and drilling) aim to fa-
cilitate the differentiation of primitive mesenchymal stem cells
from the subchondral bone into functional fibrocartilage. These
techniques are based on different types of stimulation of subchon-
dral bone. Autologous transplant (mosaicplasty) transfers intact
osteochondral plugs from non-weight bearing areas of the knee to
the lesioned area, aiming to restore cartilage congruity. Allograft
transplants use ’fresh’ donor samples to regenerate the damaged
joint area by reconstructing a functional cartilage surface.
The reparative procedures create fibrocartilage in an attempt to
substitute cartilage lesions, but no hyaline cartilage properties are
expected. These are easy and reproducible techniques that can be
readily performed when arthroscopy is available. Mosaicplasty has
the advantage of transferring cartilage and bone plugs with original
cartilage properties, but donor site complications and morbidity
are additional problems of this method. Allograft transplants have
the advantage of no donor site morbidity compared with mosaic-
plasty but have the disadvantages of potential disease transmission
and decreased cell viability.
Why it is important to do this review
Trauma related cartilage defects of the knee in adults are very com-
mon and are considered to greatly increase the risk of degenerative
changes leading to knee osteoarthritis. We intend to elucidate and
compare the effects of commonly used surgical interventions (mi-
crofracture, drilling, mosaicplasty, and allograft transplantation)
for treating isolated cartilage defects in adult knees in order to in-
form clinical practice and future research. Our review did not re-
port on autologous chondrocyte implantation, a technically more
challenging and expensive procedure, which is covered in another
Cochrane Review (Vasiliadis 2010a).
O B J E C T I V E S
To assess the relative effects (benefits and harms) of different sur-
gical interventions (microfracture, drilling, mosaicplasty, and allo-
graft transplantation) for treating isolated cartilage defects of the
knee in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised and quasi-randomised trials (using a
method of allocating participants to treatment groups which is not
strictly random, for example by patient hospital number) evalu-
ating surgical interventions (microfracture, drilling, mosaicplasty,
and allograft transplantation) for treating isolated cartilage defects
of the knee.
Types of participants
We included adults (typically older than 18 years) who were di-
agnosed and treated for symptomatic, isolated cartilage lesions on
the medial or lateral femoral condyle, trochlea, or patella. The in-
dications for surgical treatment were lesions of grades three and
four of the International Cartilage Repair Society (ICRS; Brittberg
2003; see Appendix 1). Trials focusing primarily on the treatment
of people with multiple cartilage lesions, moderate or severe os-
teoarthritis, rheumatoid diseases, and osteonecrosis were excluded.
Types of interventions
We included trials comparing different surgical interventions (mi-
crofracture, drilling, mosaicplasty, and allograft transplantation).
When presenting the results from different comparisons, we de-
fined the intervention involving the least damage to either the in-
jured area or to donor areas as the control. Thus, in a comparison
of mosaicplasty versus microfracture, microfracture was selected
as the control intervention.
We did not include trials looking at autologous chondrocyte im-
plantation because this intervention has been covered in another
Cochrane Review (Vasiliadis 2010a).
Types of outcome measures
Primary outcomes
1. Knee function, as assessed by validated tools such as the
Western Ontario and McMaster Universities Arthritis Index
(WOMAC; Bellamy 1988), Hospital for Special Surgery Score
(HSS; Lukianov 1987), International Knee Documentation
Committee Score (IKDC; Irrgang 2001), Lysholm score (Kocher
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2004; Lysholm 1982), Knee Injury and Osteoarthritis Outcome
Score (KOOS; Roos 1998).
2. Quality of life measures, as assessed by tools such as the
Short Form 36 (Ware 1992), World Health Organization -
Quality of Life (WHOQOL; Masthoff 2005), EuroQol (EQ-
5D; EuroQol Group 1990), KOOS Quality of Life subscale
(KOOS QOL; Roos 1998).
3. Failure of treatment and adverse effects (infection, revision
surgery, arthrofibrosis with stiffness, loosening of fibrocartilage
shown in ’second-look’ surgery, and donor site morbidity).
Secondary outcomes
1. Pain, using a visual analogue scale (VAS; Revill 1976) or the
KOOS Pain subscale (Roos 1998).
2. Satisfactory outcome, as rated by the patient.
3. Activity level, as assessed by tool such as the Tegner activity
level scale (Tegner 1985), ICRS (e.g. activity levels in the
Cartilage Injury Standard Evaluation Form-2000), and return to
normal daily activities.
4. Signs of quality of cartilage, as assessed by MRI,
arthroscopic appearance in ’second-look’ surgery, and histologic
quality in ’second-look’ surgery with biopsy.
Timing of outcome assessment
Outcome assessment was analysed by short-term (less than one
year), intermediate-term (one up to five years), and long-term
(more than five years) follow-up.
Search methods for identification of studies
Electronic searches
We searched the Cochrane Bone, Joint andMuscle Trauma Group
SpecialisedRegister (8 February 2016), theCochraneCentral Reg-
ister of ControlledTrials (CENTRAL;The Cochrane Library 2016,
Issue 2), EMBASE (via Ovid; 1980 to 2016 Week 5), MED-
LINE (via Ovid; 1946 to January Week 4 2016), MEDLINE
In-Process & Other Non-Indexed Citations (5 February 2016),
SPORTDiscus (via EBSCOhost; 1985 to 5 February 2016), and
LILACS: Latin American and Caribbean Health Science Litera-
ture (via Bireme IAHx interface; 1982 to 7 March 2016).
In MEDLINE, the Cochrane highly sensitive search strategy
for identifying randomised trials (sensitivity-maximizing version;
Lefebvre 2011) was combined with the subject-specific search.
Search strategies for CENTRAL,MEDLINE, EMBASE, SPORT-
Discus, and LILACS can be found in Appendix 2.
We searched the WHO International Clinical Trials Registry
Platform (WHO ICTRP), ClinicalTrials.gov, and the ISRCTN
registry for recently-concluded trials and for trials under develop-
ment (07 March 2016).
We did not apply any language restrictions.
Searching other resources
Our search included reference lists of studies and reviews,
and non-scholarly internet sources (websites of relevant medi-
cal industry and cartilage specialists). Additionally, we emailed
knee surgery researchers and societies for relevant data: the
International Cartilage Repair Society; the Anterior Cruciate Lig-
ament Study Group; the Brazilian Society of Knee Surgery;
and the International Society of Arthroscopy, Knee Surgery, and
Orthopaedic Sports Medicine. We searched the conference ab-
stracts and summaries of the following conferences (2005 toMarch
2014): ISAKOS (International Society of Arthroscopy, Knee
Surgery, and Orthopaedic Sports Medicine); SICOT (Société In-
ternationale de Chirurgie Orthopédique et de Traumatologie);
AOSSM (American Orthopaedic Society for Sports Medicine);
and AAOS (American Academy of Orthopaedic Surgeons).
Data collection and analysis
Selection of studies
Two review authors (GG and VM) independently screened titles
and abstracts of the downloaded search results for potentially eli-
gible studies. Where possible, we obtained full reports of studies
identified as potentially eligible. The same two authors indepen-
dently performed final study selection. We resolved any disagree-
ments by discussion or, if necessary, by involving a third author
for agreement to be reached (CF or PD). When there was still any
doubt about an article, we contacted the trial authors for clarifi-
cation of study details.
Data extraction and management
Two review authors (GG and VM) independently extracted data
using a data extraction form.We resolved potential author discord
through discussion or, when necessary, by involving a third author
to establish consensus (CF).
Assessment of risk of bias in included studies
Two review authors (GG and CF) independently assessed the risk
of bias of the included studies using Cochrane’s ’Risk of bias’ tool
(Higgins 2011).We resolved disagreements by consensus between
the two authors and, when necessary, by involving a third author
to establish agreement (CF or PD). We assessed the following
domains: sequence generation, allocation concealment, blinding
of participants and personnel, blinding of outcome assessment,
incomplete outcome data, and selective outcome reporting. We
judged each domain in terms of there being a ’high’, ’low’, or ’un-
clear’ risk of bias. We also assessed the influence of study sponsor-
ship or funding sources as a potential source of bias.
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Measures of treatment effect
For dichotomous outcomedata, we calculated risk ratios (RR)with
95% confidence intervals (CI). For continuous outcome data, we
calculatedmean differences (MD) with 95%CIs. If we had pooled
data for an outcome measured using different scales or scores, we
would have used the standardized mean difference (SMD) with
95%CI.We reported the number needed to treat for an additional
harmful outcome (NNTH) with 95% CI.
Unit of analysis issues
The unit of randomisation in the included studies was the indi-
vidual participant’. However, one of the 29 participants in the mi-
crofracture group in Lim 2012 had bilateral surgery and the results
for this group were presented by knees rather than participants.
We judged that the disparity between the units of analysis and
randomisation was likely to be small for this trial. As stated in our
protocol we were alert to other unit of analysis issues, including
those relating to trials with multiple treatment groups.
Dealing with missing data
We contacted authors to request any missing data, such as number
of participants, age of participants, details of dropouts, means,
measures of uncertainty (standard deviation or error), or number
of events. When we failed to acquire missing data, we presented
the available data and did not impute missing data.
Assessment of heterogeneity
The assessment of heterogeneity was done by visual inspection
of forest plots. We used the I² statistic to provide an objective
measurement of statistical heterogeneity, as recommended by the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011), with a rough guide for interpretation as follows: 0% to 40%
indicates no significant heterogeneity; 30% to 60% may represent
moderate heterogeneity; 50% to 90% may represent substantial
heterogeneity; and 75% to 100% represents considerable hetero-
geneity (Deeks 2008).
Assessment of reporting biases
In a future update, if we include more than 10 studies, we plan to
generate funnel plots to explore the possible existence of publica-
tion bias (Higgins 2011).
Data synthesis
When considered appropriate, the results of comparable groups of
trials were pooled using either fixed-effect or random-effects mod-
els; both with 95% CIs. The choice of the model was guided by
careful consideration of the extent of heterogeneity, and whether it
could be explained, in addition to other factors such as the number
and size of studies that are included. We considered not pooling
data where there was considerable heterogeneity (I² > 75%) that
could not be explained by the diversity of the clinical or method-
ological characteristics of the trials. Where it was not appropriate
to pool data, we presented trial data in the analyses or tables for
illustrative purposes and reported these results in the text.
Subgroup analysis and investigation of heterogeneity
No subgroup analyses were performed. In the future, with addi-
tional included trials and when sufficient data are available, we
plan to perform subgroup analysis in order to explore different es-
timated effects across different population demographics and pa-
tient and injury parameter subgroups. Four subgroups were de-
fined:
• Size of cartilage injury (< 2 cm² and > 2 cm²).
• Age of patients (under 45 years old and over 45 years old).
• Participant activity level (active and sedentary).
• Cartilage defects (chondral lesion) versus osteochondral
defect (osteochondral lesion); subgroup analysis added after the
protocol (seeDifferences between protocol and review).
Should we perform subgroup analysis in the future, we will inves-
tigate whether the results of subgroups are significantly different
by inspecting the overlap of CIs and performing the test for sub-
group differences that is available in RevMan.
Sensitivity analysis
When sufficient trials are available for future updates of the review,
we will perform sensitivity analyses to examine various aspects of
the trial and review methodology. This will include the effects of
excluding trials at high or unclear risk of bias, such as selection
bias arising from a lack of allocation concealment; trials including
people with osteochondritis dissecans; trials reporting only short-
term outcomes (under one year); and trials only reported in con-
ference abstracts.Wewill also investigate the effects ofmissing data
and the statistical model selected for pooling (fixed-effect versus
random-effects).
’Summary of findings’ tables
We used the GRADE approach to assess the quality of evidence
related to each of the key outcomes listed in Types of outcome
measures (Schünemann 2011). We presented a ’Summary of find-
ings’ table for the only comparison tested in the review. We re-
ported on all three primary outcomes in addition to the secondary
outcomes of pain, and activity level assessed via the Tegner score.
For both function and activity levels, we presented separate results
for intermediate and long-term follow-up.
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R E S U L T S
Description of studies
Results of the search
We screened a total of 1372 records from the following databases:
the Cochrane Bone, Joint and Muscle Trauma Group Specialised
Register (17 records); CENTRAL (78 records); MEDLINE (280
records); EMBASE (506 records); SPORTDiscus (160 records);
LILACS (214 records); the WHO ICTRP (38 records); Clinical-
Trials.gov (75 records); and the ISRCTN registry (4 records). We
also identified one potentially eligible study from searching the
ISAKOS congress meetings.
The search resulted in the identification of six reports of poten-
tially eligible studies, for which full articles were obtained. After
review, we included three studies (Gudas 2005 (published in three
articles); Lim 2012; Ulstein 2014), and excluded one (Pearsall
2014). No ongoing studies were identified and no studies await
classification.
Details of the search are illustrated in Figure 1.
Figure 1. Study flow diagram
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Included studies
Individual characteristics of the three included studies are pre-
sented in Characteristics of included studies.
One study was reported in three different reports (Gudas 2005);
we extracted all data available from all reports. Additional study
details and data were collected by communication with the con-
tact authors of two studies (Lim 2012; Ulstein 2014). Details
of the information obtained are given in the notes sections of
Characteristics of included studies. All studies were published in
English.
Design
The three included studies were randomised parallel-group con-
trolled trials. Pre-published protocols or registration documents
were not available for any trial.
Setting
Two studies were single-centre trials conducted in Lithuania and
South Korea (Gudas 2005 and Lim 2012, respectively). Ulstein
2014 was a multi-centre trial conducted in three hospitals in Nor-
way. All three trials recruited over several years: 1998 to 2002
(Gudas 2005); 2000 to 2008 (Lim 2012); and 2000 to 2006
(Ulstein 2014). Two trials had two treatment groups (Gudas 2005;
Ulstein 2014). Lim 2012 had three treatment groups, but the
participants in the third group, who were allocated to autologous
chondrocyte implantation, were not eligible for inclusion in the
review.
Sample sizes
The studies reported results for a total of 133 participants. Gudas
2005 randomised 60 people and reported results for 57 at follow-
up. Lim 2012 randomised 109 people into three groups but did
not report the numbers allocated into each group at randomisa-
tion; 40 participants (37%) were excluded, leaving 51 participants
(52 knees) followed up in the two treatment groups relevant to
this review. Ulstein 2014 randomised and reported results for 25
participants.
Participants
Table 1 presents a summary of the key participant characteristics
of each study. Gudas 2005 included young and highly compet-
itive athletes (mean age 24.4 years), 63% of whom were male.
Lim 2012 included older participants (mean age 31.8 years), of
whom 57% were male. Ulstein 2014 included older participants
(mean age 32.3 years), of whom 56% were male. Sport partici-
pation was not directly described in the latter two trials. Gudas
2005 included people with isolated cartilage lesions of ICRS grade
3 or 4, symptomatic lesions due to osteochondral defect (osteo-
chondritis dissecans), and localised defects on the medial and lat-
eral femoral condyle (1 cm² to 4 cm² in area). Lim 2012 in-
cluded people with symptomatic grade 3 and 4 lesions (Outer-
bridge grades; Outerbridge 1961), lesions of the medial or lat-
eral femoral condyle, and defects of 1 cm² to 4 cm² in area. This
study also included one participant with bilateral cartilage lesions.
Ulstein 2014 included people with isolated cartilage lesions of
ICRS grade 3 or 4, symptomatic lesions due to osteochondral de-
fect (osteochondritis dissecans), or lesions located on the femoral
condyle or trochlea with an area of 2 cm² to 6 cm² and depth < 10
mm. The mean duration of symptoms was 21.3 months in Gudas
2005 and 91.3 months in Ulstein 2014; no details on duration
were provided in Lim 2012. Further details are presented in the
’Participants’ section of Characteristics of included studies.
Interventions
All three included studies compared mosaicplasty with microfrac-
ture. Thus no study tested drilling or allograft transplantation.
Gudas 2005 and Lim 2012 reported that both procedures were
performed arthroscopically. Ulstein 2014 used minimally inva-
sive arthrotomy. Rehabilitation, considered a co-intervention, was
similar for both groups of participants in individual studies; how-
ever, each study adopted a different rehabilitation protocol (see
Characteristics of included studies). Gudas 2005 did not use con-
tinuous passive motion, whereas Lim 2012 and Ulstein 2014 did.
Outcomes
All studies reported mostly the primary outcomes listed in our
protocol (Gracitelli 2013). Knee functionwas assessedwith at least
two validated instruments (IKDC (within the ICRS evaluation
package), HSS, Lysholm, KOOS) in all articles. Quality of life was
assessed in Ulstein 2014 with the KOOS QOL. Failure of treat-
ment and adverse effects were also assessed in all articles. Reported
adverse effects were symptom recurrence and revision surgery. We
also included superficial infection as a short-term adverse effect
from Gudas 2005.
Secondary outcomes were reported in some studies. Ulstein 2014
reported on pain using the KOOS Pain subscale. Participant activ-
ity levels were assessed in all studies with the Tegner score; Gudas
2005 also used the categorisation of activity levels listed in the
ICRS standard evaluation form, and Ulstein 2014 also used the
KOOS Sport and Recreation subscale.
The quality of cartilage was assessed differently in the three trials.
Gudas 2005 arthroscopically graded macroscopic appearance ac-
cording to the ICRS in 34 participants at a mean of 12.4 months,
performing biopsy in 25 cases; at 10 years follow-up, participants
were submitted to magnetic resonance observation (MOCART)
and radiographic examination, with evaluation based on the Kell-
gren and Lawrence criteria (Kellgren 1957; Kessler 1998). Lim
2012 performed ’second-look’ arthroscopy on 52 knees (findings
were assessed using the ICRS grading system) and MRI on 61
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knees (findings were assessed using themodified Outerbridge clas-
sification (Outerbridge 1961; Potter 1998). Ulstein 2014 reported
radiographic evaluation based on the Kellgren and Lawrence cri-
teria (Kellgren 1957). The Kellgren-Lawrence grading system is
used to assess the severity of knee osteoarthritis and thus is used
as a proxy for ’quality of cartilage’ in our review.
Ulstein 2014 also reported isokinetic quadriceps and hamstring
strength measurements; these outcomes were not listed in our
protocol and thus not included in this review.
Timing of outcome assessment
The three reports of Gudas 2005 reported results at different fol-
low-up times, ranging from short to long term. The first, pub-
lished in 2005, reported results for three years follow-up (mean 37
months); the second, published in 2006, reported results at one,
two, and three years follow-up; and the third, published in 2014,
reported results at 10.4 years follow-up (range 9 to 11 years). Lim
2012 reported primary and secondary outcomes, mainly in the
long term (mean 6.3 years, range 3.2 to 10.5 years) and Ulstein
2014 reported outcomes in the long-term (median 9.8 years, range
4.9 to 11.4 years).
Excluded studies
We excluded one study (Pearsall 2014) because of the lack of ran-
domisation, as described in theCharacteristics of excluded studies.
Risk of bias in included studies
The review authors’ judgements of the risk of bias for each domain
are detailed below and in the Characteristics of included studies,
and summarised for each trial in Figure 2.Upon contact of trialists,
information on random sequence generation was provided for two
trials (Lim 2012; Ulstein 2014), and on the lack of blinding of
functional outcomes but blinding of radiographic classification in
Ulstein 2014.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Adequate methods of sequence generation were described in Lim
2012 and Ulstein 2014, which were both judged to be at low risk
of bias for this domain. Gudas 2005 did not specify the method
of sequence generation and was judged to be at unclear risk of
bias. Sealed and opaque envelopes were used in two trials (Gudas
2005; Ulstein 2014), but only Ulstein 2014 provided sufficient
assurance of concealment by their use of sequentially-numbered
envelopes. Hence, Gudas 2005 was judged to be at unclear risk
and Ulstein 2014 at low risk of selection bias relating to alloca-
tion concealment. Lim 2012 used sealed envelopes but provided
no other mention of safeguards to ensure allocation concealment.
Moreover, Lim2012 reported that participantswhodisagreedwith
their allocated procedures were excluded; thus, the allocation pro-
cess was also compromised, and the trial was judged to be at high
risk.
Blinding
No blinding of surgeons was possible because of the inherent dif-
ferences in the procedures. We judged there was an unclear risk of
performance bias for all three trials.
Gudas 2005 reported completely blinding participants and the
outcome assessment. The authors stated that only arthroscopic
procedures were performed. Lim 2012 also performed all proce-
dures arthroscopically, and had blinded assessors. Both trials were
judged to be at low risk of detection bias. Since Ulstein 2014
performed a mini-arthrotomy in the mosaicplasty group, it was
likely that participants and personnel might be aware of the type
of surgery performed according to the scar on the knee. Ulstein
2014 confirmed by email that the assessment of functional out-
comes was not blinded, and therefore this trial was judged to be
at high risk of detection bias for the primary outcome. All studies
reported blinded assessment of overall radiological (radiography
and MRI) and histological evaluations.
Incomplete outcome data
Ulstein 2014 reported no follow-up loss, and Gudas 2005 re-
ported small losses that were balanced between groups (two in
the mosaicplasty group and one in the microfracture group). Lim
2012 excluded 40 participants (37% of 109 included in the three
group trial) after randomisation and did not state how many were
randomised into each group. We judged Gudas 2005 and Ulstein
2014 to be at low risk of attrition bias, and Lim 2012 to be at high
risk.
Selective reporting
None of the three studies provided a protocol or prospective trial
registration. We judged Gudas 2005 and Ulstein 2014 as being at
unclear risk of selective reporting but Lim 2012 at high risk be-
cause of the non-reporting of functional outcome data that appear
to have been collected. Of note is that we do not have enough in-
formation to judge whether the two subgroups presented in Gudas
2005 were prespecified, which reinforces our judgement of unclear
risk of bias.
Other potential sources of bias
No studies were sponsored by the industry of medical devices.
Ulstein 2014 received a grant from a nonprofit foundation (Aker-
shus University Hospital and the Foundation of Sophies Minde).
No studies appeared to be influenced by any other study sponsor-
ship or funding sources.
Effects of interventions
See: Summary of findings for the main comparison
Mosaicplasty compared withmicrofracture for adults with isolated
cartilage defects of the knee
All three trials compared mosaicplasty with microfracture. The
results are presented as overall findings of the trials, including
primary and secondary outcomes. Where available, separate data
for function, activity, adverse effects, and return to normal daily
activities are presented for three time periods: short-term (up to
one year); intermediate-term (one up to five years); and long-term
(five or more years). When trials included more than one measure
of function, we chose the IKDC score (included in the ICRS
cartilage injury evaluation package but referred to as ICRS scores
in Gudas 2005) and Lysholm score rather than HSS score and
KOOS score. Lysholm is themost commonly used in the literature
and the combination of the five separate scores comprising the
KOOS score is not recommended.
Overall analysis of mosaicplasty versus microfracture
Function
One trial reported intermediate term results (Gudas 2005) and all
three presented long term results, although those reported for Lim
2012 ranged from 3 to 10.5 years.
Assessing function via the IKDC 2000 score (0 to 100, 100 being
the best score), Gudas 2005 (57 participants) found a statistically
significant and clinically important difference in favour of mosaic-
plasty at one year (MD 10.29, 95% CI 7.87 to 12.71; very low
quality evidence; see Analysis 1.1). This difference also continued
at three years (mean 89 versus 75; reported P < 0.001).
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The other two trials assessed function via the Lysholm score (0
to 100, 100 being the best score). Since the long term results for
Gudas 2005 were markedly different and substantially heteroge-
neous from those of the other two trials, we did not pool the long
term data from all three trials (see Analysis 1.2). Pooled Lysholm
scores from Lim 2012 and Ulstein 2014 showed no clinically im-
portant difference between the two groups (MD -1.10, 95% CI -
4.54 to 2.33; 72 participants; very low quality evidence). Gudas
2005 presented function data subgrouped by whether the cartilage
injury was caused by trauma (only chondral lesions) or by osteo-
chondritis (osteochondral lesions); as the subgroup results were
very similar, we combined these to produce a result for the overall
group. As at intermediate follow-up, the findings of Gudas 2005
strongly favoured the mosaicplasty group (MD 13.97, 95% CI
13.25 to 14.69; 57 participants; very low quality evidence).
Quality of life
Ulstein 2014 found no significant between-group difference in
long-term quality of life measured via the KOOS QOL score (0
to 100, 100 being the best score; MD -7.00 favouring microfrac-
ture, 95% CI -25.23 to 11.23; 25 participants; very low quality
evidence, see Analysis 1.3). The Minimal Detectable Change in
patients with knee injury is 7 to 7.2 for KOOS QOL; KOOS.
Failure of treatment and adverse effects
All three trials reported on treatment failure. Only Gudas 2005
gave some details of the timing of ’failure’, whereas Lim 2012
and Ulstein 2014 reported only on those requiring a re-operation
during follow-up.
Gudas 2005 reported that two participants in the mosaicplasty
group had superficial infections which resolved with antibiotics.
They confirmed that there was no donor-site morbidity in this
group.
There were some common characteristics in the reported failures
and revision surgeries in the three trials. Gudas 2005 reported
10 failures (one mosaicplasty versus nine microfracture) occurring
up to one year after surgery; revision surgery comprised mosaic-
plasty in eight of the nine microfracture participants. A further
five patients experienced failure (two mosaicplasty versus three
microfracture) at an average of 5.8 years in Gudas 2005, four of
whom had revision surgery comprising mosaicplasty. A prominent
osteochondral plug was reported as failed treatment prompting
revision surgery in the mosaicplasty group of both Gudas 2005
and Lim 2012. Three microfracture participants also had re-oper-
ations in Lim 2012. Of the 11 re-operations or additional surgical
procedures (five mosaicplasty versus six microfracture) in Ulstein
2014, all three participants having a second cartilage procedure
belonged to the microfracture group; another participant in this
group had a total joint replacement.
Pooled results for treatment failure reported at long-term follow-
up in the three trials showed recurrence and re-operations were
significantly fewer in the mosaicplasty group (10/64 versus 20/
65; RR 0.47, 95% CI 0.24 to 0.90; very low quality evidence; see
Analysis 1.4). The majority of failures (10 of 15) in Gudas 2005
occurred by 12month follow-up andweremainly for symptom re-
currence; all had revision surgery. This result equates to anNNTH
of 6 (95% CI 4 to 34); hence, one additional person will have
revision surgery for every six participants receiving microfracture
rather than mosaicplasty over 10 years follow-up.
Pain
Measured using the pain component of the KOOS score (0 to
100, 100 being the best score), Ulstein 2014 found no significant
between group difference in pain at 9.8 years follow-up (MD -
7.50 favouring microfracture, 95% CI -26.06 to 11.06; 25 partic-
ipants; very low quality evidence; see Analysis 1.5). The Minimal
Detectable Change in patients with knee injury is 6 to 6.1 for
KOOS Pain; KOOS.
Activity
All trials reported data regarding activity based on Tegner scores
(1 to 10, 10 being the best score). The Tegner score results for
Gudas 2005 are summed from separate subgroup data provided
for chondral and osteochondral lesions; there was no evidence to
support subgroup differences. The evidence for all activity results
was rated very low quality.
Gudas 2005 reported higher Tegner scores in the mosaicplasty
group at three-year (intermediate) follow-up (MD 0.48, 95% CI
0.21 to 0.75; 57 participants; see Analysis 1.6), but the difference
between the two groups may not be clinically important.
Because of clear statistical and clinical heterogeneity, we did not
pool the long term Tegner score results (see Analysis 1.7). Gudas
2005 continued to report higher Tegner scores in the mosaicplasty
group at 10 years follow-up (MD 0.72, 95% CI 0.46 to 0.98; 57
participants); but again the between group difference may not be
clinically important. Lim 2012 found no difference between the
two groups at an average of 6.3 years (MD 0.20, 95% CI -0.57 to
0.97; 47 participants). Ulstein 2014 found no significant between
group difference in Tegner scores at 9.8 years follow-up:MD -1.04
favouring microfracture, 95% CI -2.56 to 0.48; 25 participants.
OnlyGudas 2005 reported on the return to normal daily activities,
which was expressed in terms of sports given that all participants
in the trial had been athletes (see Analysis 1.8). Gudas 2005 found
a greater return to a pre-injury level of sports activities in the
mosaicplasty group (26/28 versus 15/29; RR1.80, 95%CI 1.24 to
2.59); return to sports activities occurred at a mean of 6.5months.
There was also greater sports continuation in the mosaicplasty
group at three years (25/28 versus 8/29; RR 3.24, 95% CI 1.77
to 5.92) and 10 years (10/28 versus 5/29; RR 2.07, 95% CI 0.81
to 5.30), although the 95% CI crossed the line of no effect for the
latter.
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Quality of cartilage
Quality of cartilage was assessed with MRI (Outerbridge and
MOCART scores), arthroscopic ’second-look’ surgery, histologi-
cal evaluation after cartilage biopsy and, as a proxy, radiographic
imaging characteristics of arthritis.
Lim 2012 found little between-group difference in the numbers
of participants with satisfactory cartilage characteristics (grades 1
and 2 of Outerbridge’s modified classification system) on MRI
assessment at one year follow-up (17/20 versus 20/25; RR 1.06,
95% CI 0.81 to 1.39; 45 participants; very low quality evidence;
see Analysis 1.9). The MRI results of all 57 participants followed
up at 10 years in Gudas 2005 were assessed according to different
items of the MOCART score. As shown in Analysis 1.9, there
were more satisfactory results in the mosaicplasty group for most
of the individual features (e.g. complete degree of defect repair
and filling: 21/28 versus 10/29; RR 2.17, 95% CI 1.26 to 3.75;
intact subchondral bone: 26/28 versus 12/29; RR 2.24, 95% CI
1.44 to 3.50).
Pooled data for excellent or good results on arthroscopic ’second-
look’ surgery conducted at around one year in a subgroup of par-
ticipants from two trials did not show a difference between the
two groups (25/31 versus 25/40; random-effects RR 1.28, 95%
CI 0.74 to 2.21; I² = 67%; 71 participants; very low quality evi-
dence; see Analysis 1.10). Gudas 2005, reporting on a subgroup
of 25 participants who were submitted to a “second look” surgery
conducted on average at 12.4 months follow-up, found that all
participants of the mosaicplasty group displayed hyaline cartilage
of a normal appearance but none in the microfracture group (11/
11 versus 0/14; RR 28.75, 95% CI 1.88 to 439.84; very low qual-
ity evidence; see Analysis 1.11).
The radiographic characteristics of arthritis were based on theKell-
gren and Lawrence classification system (Grade 1: doubtful nar-
rowing of joint space and possible osteophytic lipping; Grade 2:
definite osteophytes, definite narrowing of joint space; Grade 3:
moderate multiple osteophytes, definite narrowing of joints space,
some sclerosis and possible deformity of bone contour; Grade 4:
large osteophytes,marked narrowing of joint space, severe sclerosis
and definite deformity of bone contour; Kellgren 1957). Pooled
data from two trials of participants with radiographically-defined
osteoarthritis showed a significant difference in favour of mosaic-
plasty (9/40 versus 19/40; RR 0.48, 95% CI 0.25 to 0.92; I² =
0%; very low quality evidence; see Analysis 1.12).
Sensitivity analyses
Sensitivity analyses were not performed because of the small num-
ber of studies.
D I S C U S S I O N
Summary of main results
Our systematic review included three randomised controlled tri-
als, all of which compared mosaicplasty with microfracture for
treating isolated cartilage defects of the knee in adults. These re-
ported results for a total of 133 participants, of whom 79 (59%)
were male.Mean ages of trial participants in the three trials ranged
between 24.4 and 32.3 years. No trials of allograft transplantation
or drilling were identified. We presented data from three trials for
several outcomes (function, quality of life, pain, activity, return
to normal daily activities, quality of cartilage on MRI, quality of
cartilage measured by the presence of hyaline cartilage). It is clear
throughout that the results of one small trial involving athletes
only strongly favoured mosaicplasty (Gudas 2005), while the find-
ings of the other two small trials were more conservative (Lim
2012; Ulstein 2014). The main results of the mosaicplasty versus
microfracture comparison are presented in Summary of findings
for the main comparison and summarised below.
There is very low quality evidence from one single-centre trial (57
participants), recruiting athletes only, that mosaicplasty probably
resulted in better patient-reported function at one, two, and three
years follow-up compared with microfracture. Very low quality
evidence from the same trial showed that this effect persisted in
the long-term at 10 years follow-up. However, there is very low
quality evidence from the two other trials (72 participants) of little
difference in patient-reported function between the two groups
at long-term follow-up. One trial (25 participants) provided very
low quality evidence of no significant difference between the two
groups in quality of life or pain at long-term follow-up. Pooled
results for treatment failure, primarily symptom recurrence, re-
ported at long-term follow-up in the three trials (129 participants)
favoured mosaicplasty. Based on an illustrative risk of 379 treat-
ment failures per 1000 patients treated with microfracture, there
is very low quality evidence that 201 fewer patients (95% CI 288
to 38 fewer) would have treatment failure after mosaicplasty. All
three trials reported activity scores, but due to clear statistical and
clinical heterogeneity, we did not pool the long term Tegner score
results. There was very low quality evidence from one study (57
participants) of higher Tegner scores, indicating greater activity, in
the intermediate-term and long-term in the mosaicplasty group;
however, the between group difference may not be clinically im-
portant. The other two trials provided very low quality evidence
of no difference between the two groups in activity scores.
Overall completeness and applicability of
evidence
The limited evidence available is for the mosaicplasty versus mi-
crofracture comparison only.We found no trials of allograft trans-
plantation or drilling. The three small heterogeneous trials in-
cluded in this review provided data for a total of 133 participants
undergoing treatment for isolated knee cartilage lesions. One trial
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recruited patients from three centres, whereas the other two were
single-centre studies. Only a few participants were lost to follow-
up in two trials (Gudas 2005; Ulstein 2014), but there was a large
but not quantifiable loss to follow-up in Lim 2012.Where data for
common outcomes were available (e.g. Tegner scores), we often
did not pool these because of substantial statistical heterogeneity.
Isolated cartilage lesions are relatively rare in clinical practice,
which helps explain the few trials with long recruitment times
noted in this review. Generally, meniscal and ligament injuries
are concomitant lesions resulting from the same traumatic event.
Hence, the majority of clinical trials available in the literature for
cartilage lesion in the knee include meniscal and ligament injuries
(Gudas 2013). Selecting patients with isolated lesions reduces con-
founding from other injuries; however, extrapolating the trial re-
sults to the more common presentations is not straightforward.
Additionally, other patient characteristics may have influenced the
results.
As illustrated in Table 1, the available baseline characteristics data
show substantial differences in the trial populations. We suspect
that heterogeneity in the trial results reflects in part the differ-
ent populations in these trials. Although there is some overlap
in terms of population selection for some characteristics, there is
a notable contrast between Gudas 2005, which selected younger
athletes with relatively small lesions presenting on average at 21.3
months, and Ulstein 2014, which featured a very substantial delay
to treatment (mean 91.3 months) in a less active and older popu-
lation. Mean lesion sizes were comparable in the three trials, but
Ulstein 2014 included some participants with lesions greater 4.0
cm². This is compatible with their decision to use mini-arthro-
tomy for mosaicplasty. To achieve a smooth cartilage surface af-
ter plug implantation, perpendicularity is considered crucial ac-
cording to the originally described surgical technique (Hangody
1998).Whenmore thanone plug is required, it ismore challenging
to perform mosaicplasty arthroscopically, and hence the rationale
for the adoption of mini-arthrotomy because of larger defects by
Ulstein 2014. Gudas 2005 and Lim 2012 performedmosaicplasty
arthroscopically in all cases independent of cartilage size. Previous
case series studies that included microfracture have shown better
results from microfracture with lesions less than 4 cm² compared
with larger lesions (Knutsen 2007; Steadman 2003). However, the
consequences of including larger sized defects in Ulstein 2014 was
not clear. Cartilage lesion location is controversial in terms of the
extent to which it influences final microfracture and mosaicplasty
outcomes (Kreuz 2006; Mithoefer 2006). Only Ulstein 2014 re-
ported cartilage lesions in the trochlea (just two were included),
whereas the other trials only included femoral condyle lesions.
Notably, none of the studies included the more difficult-to-treat
patella lesions. Concomitant pathologies such as patellofemoral
instability, dysplasia and malalignment make patella lesions more
challenging to treat as well as to study.
Higher preoperative activity rates (Tegner score > 4) have been
shown to influence the function and activity outcomes of mi-
crofracture in other studies (Knutsen 2004; Mithoefer 2006).
Moreover, younger patients have been shown to have higher func-
tion scores and greater cartilage filling on MRI (Knutsen 2007;
Kreuz 2006; Mithoefer 2006). The lower duration of symptoms
is also associated with higher function outcomes in some retro-
spective studies (Solheim 2016). Thus Gudas 2005 has a popu-
lation that is likely to do better whatever the intervention used.
Whether this partially explains the different results for this trial
favouring mosaicplasty compared with the other two trials is not
clear and there were no data for subgroup analyses, including our
preplanned subgroup analyses, which included an age threshold
of 45 years.
Quality of the evidence
The quality of evidence available was downgraded three levels
for all outcomes for which data were presented. Thus, overall we
judged the evidence to be of very low quality, which indicates that
we are very uncertain about the estimates for all outcomes. The
justification for downgrading for each outcome is summarised in
the footnotes of Summary of findings for the main comparison.
Where the evidence was available from Gudas 2005 alone, we
downgraded it one level for serious limitations due to risk of bias
(insufficient information about sequence generation and alloca-
tion concealment, lack of blinding of surgeons; possible selective
reporting). Where evidence was available for either the other two
trials or in combination with Gudas 2005, we downgraded it two
levels for serious limitations in design and implementation that
related to one or more domains at high risk of bias (e.g. lack of
allocation concealment and lack of blinding of outcome assess-
ment) as well as other domains at unclear risk of bias (see Figure
2).
Where evidence was available from a single-centre trial only
(Gudas 2005; Lim 2012), we downgraded the evidence one level
for indirectness. Single centre trials may include mainly experts
and highly trained surgeons in cartilage treatments, specially in
mosaicplasty treatment, which requires a longer time of training,
especially when performed arthroscopically. This is because we
are uncertain whether the results, which may reflect the special
characteristics of the centre including the specific expertise of the
operating surgeons, are applicable more generally.
We downgraded the evidence for intermediate- and long-term
function one level for inconsistency, even though data pooling was
not undertaken and evidenced of inconsistency was available only
in the long term.
We downgraded the evidence for several outcomes (e.g. Lysholm
scores, treatment failure) one level for serious imprecision reflect-
ing wide confidence intervals, small sample size, or low numbers
of events.
We did not downgrade for publication bias since we obtained no
evidence of this.
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Potential biases in the review process
Our search was comprehensive with no language restrictions ap-
plied, but the availability of other trials, which are likely to have
been small and unpublished, cannot be ruled out.
We followed our protocol where possible; the few differences be-
tween the review and the protocol methods are shown in the
Differences between protocol and review. Two areas of difference
lay in our post-protocol selection of functional scores for presen-
tation and introduction of another subgroup analysis for future
use. In our judgement, neither action would have introduced bias:
there was consistency in the results of the different functional
scores presented in the individual trial reports; and we did not per-
form the new subgroup analysis, which is set up should sufficient
data be available in the future.
Agreements and disagreements with other
studies or reviews
In the literature, there are many narrative and systematic reviews
that address all of the different cartilage repair and reconstruc-
tion treatments, including some of the interventions included in
this review. We found many narrative reviews (and discuss one of
these; Gomoll 2010b), and three systematic reviews, that partially
overlap with ours (Goyal 2013; Goyal 2014; Mithoefer 2009).
The comprehensive instructional course lecture of Gomoll 2010b
considers patient demand and lesion size as key determinant char-
acteristics for treatment decisions. Based on the findings of Gudas
2005,Gomoll 2010b recommendedmosaicplasty for patientswith
small lesions (< 4 cm²) and high-demand athletes, and microfrac-
ture for patients with lower demands. Gomoll 2010b also points
to surgeon preference and familiarity with the two techniques as
having a role in decision making and concludes that the available
surgical procedures should be seen as “complementary, rather than
competitive, allowing treatment of the entire spectrum of lesions”.
Mithoefer 2009 included 28 studies, of which only six were ran-
domised controlled trials; the others were prospective cohort, ret-
rospective cohort and case series. Microfracture was the only in-
tervention explored, and one of the reports, published in 2005
and included in our review, was also selected (Gudas 2005). The
authors reported that microfracture improved knee function in all
studies in the short term, but that these results showed no dura-
bility. MRI findings were variable and correlated with function
outcomes, and they also suggested that the ’second-look’ surgery
with poor quality of tissue formed correlates with increased long-
term failure rate. However, only three studies included ’second-
look’ surgery as a primary outcome. Microfracture was not com-
pared with any other techniques in this review. A key shortcoming
of this review was the high heterogeneity, which we also found in
our included participants, in lesion characteristics (acute, chronic,
chondral, or osteochondral, location, number, and size), concomi-
tant procedures (meniscal, high tibia osteotomy, and ligament re-
construction), and participant age.
Both of the more recent systematic reviews also included ran-
domised controlled trials or prospective cohorts (Goyal 2013;
Goyal 2014). Goyal 2013 focused on microfracture and Goyal
2014 on mosaicplasty. Both included Gudas 2005 but presented
the results from the three reports of this trial as if they were
three separate studies; and both included Lim 2012. Goyal 2013
concluded that microfracture gave positive short-term results in
younger patients and patients with only small lesions but that
treatment failure occurred after five years regardless of cartilage
lesion size. Goyal 2014 referred to the findings from Gudas 2005
in terms of positive results for mosaicplasty over microfracture for
younger patients with small lesions, but concluded there was in-
sufficient evidence in long-term follow-up to draw conclusions.
Both reviews were biased because of the double counting of the
short term results of Gudas 2005.
The findings of Gudas 2005 are influential in all four articles
discussed above. We add a note of caution in that the results of
one small single-centre trial may not be representative, even for
the more specific population, and always require confirmation.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found no evidence from RCTs on allograft transplantation or
drilling. The very low quality evidence fromRCTs comparingmo-
saicplasty withmicrofracture is insufficient to draw conclusions on
the relative effects of these two interventions for treating isolated
cartilage defects of the knee in adults. Of note is that treatment
failure, with recurrence of symptoms, occurred with both proce-
dures.
Implications for research
In recent years, the diagnosis of cartilage lesions has increased due
to increased availability of non-invasive examination techniques
(MRI) and incidental findings of cartilage lesions in commonly
performed arthroscopic surgeries. Microfracture and mosaicplasty
are internationally-available methods of treatment, whereas allo-
graft transplantation remains limited predominantly because of
supply issues. Drilling was believed to be associated with thermal
necrosis of subchondral bone and was abandoned for many years.
However, the development of small and arthroscopic drills with
continuous irrigation and homogenous perforation of the sub-
chondral bone has increased its use as a cartilage treatment option.
These observations help explain the restriction in the current re-
view to trials comparing microfracture and mosaicplasty.
Further RCTs, that conform to best methods and reporting stan-
dards, are needed to define the best surgical option for treating
isolated cartilage defects. Ideally, such trials will be multi-centre in
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order to assure sufficient numbers of patients and increase exter-
nal applicability. Well defined and described populations, broadly
stratified by key characteristics relating to prognosis such as age and
size of cartilage defect to facilitate subgroup analysis, are required.
Validated patient-reported outcome scores of function with long-
term follow-up (10 years) should be considered to assess the on-
set of adverse effects and the development of osteoarthritis. We
propose that two key areas of research are trials including patients
with large osteochondral lesions treated with reconstructive proce-
dures (mosaicplasty versus allograft transplantation), with repara-
tive procedures (microfracture versus drilling) reserved for solely
chondral and smaller lesions.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Gudas 2005
Methods Randomised controlled trial: use of sealed envelopes.
Participants were followed for three years (first and second reports) and for 10 years
(third report). Follow-up assessors were blinded to outcomes
Trial location: KaunasUniversityHospital, Kaunas, Lithuania; recruitment 1998 to 2002
Participants Participants: 60 athletes with symptomatic isolated cartilage lesions in the knee were
randomised to undergo either mosaicplasty (30 participants) or microfracture (30 par-
ticipants). Mean age 24.3 years, range 15 to 40. Three participants lost to follow-up: 57
were followed-up (28 versus 29)
Included participants: Adult athletes with isolated cartilage lesions of ICRS grade 3
or 4, symptomatic lesions due to osteochondral defect (osteochondritis dissecans), and
localised defects on the medial and lateral femoral condyle (1 cm² to 4 cm²)
Excluded participants: Patients with generalised chondromalacia or osteoarthritis, lesions
larger than 4 cm² or smaller than 1 cm², patients older than 41 years, and patients with
any misalignment or instability of the knee
Age:
OAT group mean (SD): 24.6 years (6.54)
MF group mean (SD): 24.3 years (6.80)
Gender:
OAT group (number of men/women): 19/9
MF group (number of men/women): 17/12
Sports activity: All participants were athletes.
Duration of symptoms: 21.3 months (SD 5.6 months)
Interventions This study included only all-arthroscopic mosaicplasty and microfracture procedures.
No other incision was used
Mosaicplasty or osteochondral autograft transplantation:
Standard procedure described in literature with the arthroscopic osteochondral autograft
transfer system (OATS; Arthrex®). An average of 4.3 osteochondral plugs (range 3 to 6
plugs) were used per surgery
Microfracture:
The standard MF procedure for cartilage defect lesions was performed. When treating
OCD caused by osteochondritis dissecans, the OCD fragments were removed and de-
brided, and then the microfracture was performed
Co-interventions:
The same rehabilitation programme for both groups. In the first weeks, achieving full
range ofmotionwas emphasised.No continuous passivemotionwas used in either group.
All participants were allowed to walk with crutches. Weight bearing was prohibited for
4 weeks. Partial weight bearing (20 kg) was permitted after 4 weeks. No postoperative
brace was used. After 8 weeks, participants progressed to full weight bearing. Depending
on the clinical status, participants were allowed to gradually return to sports at 4 to 6
months post-operation
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Gudas 2005 (Continued)
Outcomes Primary outcomes:
IKDC score (this is the 2000 version included in the ICRS cartilage injury evaluation
package but referred to as the ICRS score in this trial)
HSS Score
Failure: revision surgery
Complication: infection
Secondary outcomes:
Activity level: Tegner Activity Scale and ICRS (based on activity levels in the ’Standard
Evaluation Form’)
Quality of cartilage:
“Second look arthroscopy”: macroscopic ICRS grade and biopsy
Magnetic resonance observation of cartilage repair tissue score system (MOCART)
Notes No additional data retrieval was possible after multiple contact attempts
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information about the se-
quence generation process to permit judge-
ment
Allocation concealment (selection bias) Unclear risk Used opaque and sealed envelopes; inade-
quate mention of safeguards
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were blinded to the interven-
tion, but surgeons cannot be blinded for
different interventions
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk A blinded observer performed preoperative
and follow-up outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data were balanced in
numbers across intervention groups. Only
3 participants (2mosaicplasty, 1 microfrac-
ture) lost to follow-up
Selective reporting (reporting bias) Unclear risk The study protocol is not available.
Other bias Low risk The study seems free of other sources of
bias.
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Lim 2012
Methods Randomised controlled trial: use of sealed envelopes.
Participants were followed for a minimum of three years (mean 5.7 years; range 3 to 10.
5 years for the whole trial; mean 6.3 years; range 3.2 to 10.5 years for the comparison
included in review). Follow-up assessors were blinded to outcomes
Trial location: Korea University Medical Center, Guro Hospital; recruitment 2000 to
2008
Participants Participants: follow-up results reported for 51 people with symptomatic isolated carti-
lage lesions in the knee randomised to undergo either mosaicplasty (22 participants) or
microfracture (29 participants; 30 knees). Mean age: 31.8 years (range in whole trial: 18
to 42 years)
Included participants: Patients with symptomatic grades 3 and 4 lesions (Outerbridge
grades), lesions of the medial or lateral femoral condyle and defects of 1 cm² to 4 cm²
in area. One participant from the microfracture group had both knees included in the
study
Excluded participants: Authors do not establish clear exclusion criteria, but of the 109
people in the trial (3 treatment groups), 29 participants were excluded because of incom-
plete follow-up (4 were lost to follow-up & 2 died) and 11 participants were excluded
because they had undergone a secondary arthroscopic procedure to treat ligament or
meniscal injuries or intraarticular infections. The excluded participants were from all
three groups of intervention (microfracture, mosaicplasty, and autologous chondrocyte
implantation) but numbers of participants excluded from each group were not reported
Demographic and outcome data are based on 51 participants (52 knees) after exclusion
Age:
OAT group mean (range): 30.4 years (20 to 39)
MF group mean (range): 32.9 years (22 to 42)
Gender:
OAT group mean (number of men/women): 12/10
MF group (number of men/women): 17/12
Lesion size:
OAT group mean area (range): 2.75 cm² (1.0 cm² to 54.0 cm²)
MF group mean area (range): 2.77 cm² (1.2 cm² to 3.6 cm²)
Sports activity (Tegner activity level score pre-op):
OAT group mean (SD): 2.7 (1.5)
MF group mean (SD): 2.8 (1.4)
Duration of symptoms: not stated
Interventions This study included only all-arthroscopic mosaicplasty and microfracture procedures
Mosaicplasty or osteochondral autograft transplantation:
Standard procedure was performed and detailed. After debridement of the fibrillated
cartilage, the size of the lesionwasmeasured using a 5mmgraduated probe and size tamp.
To prepare the recipient site, the recipient tube harvester was placed over the defect. The
harvesting device was perpendicular to the articular surface at the time of graft harvest.
The grafts were inserted congruently so that they were not proud or recessed and they
were supported at the base of the bone tunnels. They used plugs of 4, 6, and 8 mm in
diameter. Each donor transplant was harvested with a larger (0.1 mm) cylinder, and the
lesion was carved out with a smaller cylinder so that a press-fit transplantation of the
osteochondral cylinder could be achieved. All plugs were placed at the same level with
the healthy cartilage
Microfracture:
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Lim 2012 (Continued)
Standard microfracture was performed and detailed. Cartilaginous remnants on the
subchondral bone were debrided fully with an arthroscopic curette and shaver. Conical
holes of 0.5 mm to 1 mm in diameter and 4 mm deep were punched throughout the
defect at a distance of 3 mm to 4 mm apart with awls
Mosaicplasty:
Standard mosaicplasty performed arthroscopically.
Microfracture:
Standard microfracture performed arthroscopically.
Co-interventions:
The rehabilitation programme was the same for both groups and after all operative
techniques. Participants were told to perform certain rehabilitative exercises using a
continuous passive motion device 2 to 4 hours per day for 6 to 8 weeks. Participants
were allowed to bear weight partially on their tiptoes for 6 to 8 weeks. After 8 weeks, full
weight bearing was permitted, and the participants returned to work. Normal activities
of daily living were resumed 4 to 6 months after treatment
Outcomes Primary outcomes:
Lysholm score
HSS Score
Failure: revision surgery
Secondary outcomes:
Activity level: Tegner activity scale
Quality of cartilage:
“Second look arthroscopy”: macroscopic ICRS grade
Magnetic resonance image (Outerbridge grade)
Notes The third treatment group of this study (autologous chondrocyte implantation) was not
included in this review. This study also based its power analysis on a secondary outcome
(arthroscopic evaluation) rather than the function outcomes
The contact author provided additional information by e-mail: mosaicplasty was done
arthroscopically; use of a computer programme for sequence generation; and no protocol
was ever registered
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk This was not stated in the paper, but it is
unclear due to lack of description. The au-
thor contacted said the randomisation was
done by a computer programme
Allocation concealment (selection bias) High risk Sealed envelopes were prepared, but there
was no mention if they were opaque. Four
patients were excluded because their choice
of surgical procedure influenced the surgi-
cal procedure chosen
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Lim 2012 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were blinded to the interven-
tion, but surgeons cannot be blinded for
different interventions
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The outcome assessment was done by
blinded persons.
Incomplete outcome data (attrition bias)
All outcomes
High risk 109 participants (120 knees) were recruited
into the 3 groups. Of these, the author ex-
cluded 29 participants (4 patients lost to
follow-up, 23 did not have adequate serial
functional scores at 1, 6, 12, 24 and 36
months postoperatively, and 2 participants
died) and a further 11 participants who had
undergone a secondary arthroscopic proce-
dure unrelated to the cartilage procedure.
The numbers randomised into the mosaic-
plasty and microfracture groups were not
given
Selective reporting (reporting bias) High risk The study protocol was not registered.
Outcomes were collected at regular inter-
vals before 3 years and those without “ad-
equate serial functional scores at 1, 6, 12,
24, and 36 months postoperatively” were
excluded. Thus interim outcomes and out-
come at 3 years were probably planned to
be reported
Other bias Unclear risk One participant had both knees included
in the study.
Ulstein 2014
Methods Randomised controlled trial: participants were randomised utilising the block procedure,
and allotments were kept in sealed, opaque envelopes. There were no blinded follow-
up assessments of primary outcomes. Participants were followed for median 9.8 years
(range 4.9 to 11.4)
Trial location: 3 different hospitals in Norway: Martina Hansens Hospital, Bærum; Oslo
University Hospital, Oslo; Akershus University Hospital, University of Oslo. Recruit-
ment: November 2000 to June 2006
Participants Participants: 25 adults with chondral lesion in the knee were randomised to undergo
eithermosaicplasty (14participants) ormicrofracture (11participants); all were followed-
up
Included participants: Adults with isolated cartilage lesions ICRS grade 3 or 4, adults
with symptomatic lesions due to osteochondral defect (osteochondritis dissecans), or
29Surgical interventions (microfracture, drilling, mosaicplasty, and allograft transplantation) for treating isolated cartilage defects of the
knee in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ulstein 2014 (Continued)
lesions located on the femoral condyle or trochlea, with an area between 2 cm² and 6
cm² and depth < 10 mm. Participants had to be 18 to 50 years of age with Lysholm score
< 80 and Tegner score < 6
Excluded participants: Patients with radiographic osteoarthritis, major misalignment,
major ligament injury or instability, extension deficit > 3 degrees, flexion deficit > 5
degrees and chondral lesions of ICRS grade 3 or 4 on the tibial plateau or patella. Patients
had contralateral impaired knee function that could have influenced their ability to
follow the rehabilitation protocol
Age:
OAT group mean (SD): 32.7 years (7.8)
MF group mean (SD): 31.7 years (8.0)
Gender:
OAT group (number of men/women): 8/6
MF group (number of men/women): 6/5
Lesion size:
OAT group median area (range): 3.0 cm² (2.0 cm² to 6.0 cm²)
MF group median area (range): 2.6 cm² (2.0 cm² to 5.2 cm²)
Sports activity (Tegner activity level score pre-op):
OAT group median (range): 2.5 (0 to 4)
MF group median (range): 3 (0 to 4)
Duration of symptoms:
OAT group mean (SD): 75.8 (73.5) months
MF group mean (SD): 111.0 (75.8) months
Interventions This study included OAT/mosaicplasty performed through a medial parapatellar arthro-
tomy or a mini-invasive arthrotomy. Microfracture was performed all-arthroscopically
Mosaicplasty or osteochondral autograft transplantation:
Standard procedure described in the literature with press-fit fixation (Acufex: Smith&
Nephew)
Mosaicplasty was performed through amedial parapatellar arthrotomy or amini-invasive
arthrotomy, depending on the lesion size and localization. Debridement was done similar
to that described for MF. The OATmosaicplasty procedure was performed by obtaining
small cylindrical osteochondral grafts (3.5 mm, 4.5 mm, or 6.6 mm in diameter) from
the minimal weight-bearing periphery of the femoral condyles and transplanting them
“press-fit” to recipient tunnels in the prepared lesion site. At the end of the procedure, the
knee was moved through a full range of motion to check the stability of the osteochondral
plugs
Microfracture:
The procedure was arthroscopic and followed the standard procedures. Debridement of
all damaged and unstable cartilage was performed, so as to obtain stable and healthy
cartilage edges. An arthroscopic awl (Linvatec) was then used to perform multiple holes
(“microfractures”) about 3 mm to 4 mm apart. The depth of the holes was considered
appropriate when “fat-pearls” emerged from the subchondral bone
Co-interventions:
The same rehabilitation program for both groups. All participants were hospitalised for
a minimum of 5 days. Continuous passive motion (Kinetec®) 3-4 H 2x/day began on
the first post-operative day and continued for four days. Cold therapy and compression
(Aircast Knee Cryo/Cuff®) were applied the two first days post-operation
A maximum load of 15 kg to 20 kg weight bearing was allowed the initial 6 weeks post-
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Ulstein 2014 (Continued)
operation, gradually discontinuing the use of crutches up to 8 weeks. From 8 weeks,
progression to full weight bearing was encouraged. Physiotherapist-guided rehabilitation
was initiated immediately post-operation andwas continued for aminimumof 6months.
Participants were generally allowed return to full activity after 6 months. However,
participation in competitive contact sports or other activities that could expose the knee
to pivoting forces was discouraged until 12 months post-operation
Outcomes Primary outcomes:
Lysholm Score
KOOS
Failure: revision surgery (reoperation: ACI, OAT, proximal tibia osteotomy, loose body,
debridement, and knee replacement)
Complication: No complication mentioned
Secondary outcomes:
Activity level: Tegner activity scale
Quality of cartilage:
Radiographic arthrosis evaluation with Kellgreen and Lawrence criteria
Notes The study was underpowered for the main outcome.
Grant research support from Akershus University Hospital and the Foundation of So-
phies Minde
The contact author provided additional information and data by e-mail: this included
the raw data fromwhich we extracted theKOOSQuality of life, KOOSPain, and Tegner
results, the recently published article, and othermethodological information on blinding
Author’s information: “We did not perform blinding of the patients or the personnel due
to the fact that microfracture» was performed arthroscopically vs the mini open OAT
mosaicplasty». The skin wound/scar would be different in the two groups.” “When it
comes to the outcomes, the personnel (physiotherapists and orthopedic surgeons) were
blinded when rating the Kellgeren-Lawrence score in anonym[ised] radiographs, and
when performing the dynamometer strength tests.”
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A block randomisationwas performedwith
a block size of 10 participants
Allocation concealment (selection bias) Low risk Used sequentially-numbered, opaque, and
sealed envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk There was no blinding of participant and
personnel.
Blinding of outcome assessment (detection
bias)
All outcomes
High risk There was no blinding of primary out-
comes.
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Incomplete outcome data (attrition bias)
All outcomes
Low risk No participants were lost to follow-up.
Selective reporting (reporting bias) Unclear risk No protocol was available for comparison.
Other bias Low risk The study received grant support from Ak-
ershus University Hospital and the Foun-
dation of Sophies Minde. This foundation
is a non-profit institution and the study is
not biased by this grant
ACI: autologous chondrocyte implantation
HSS: Hospital for Special Surgery
ICRS: International Cartilage Repair Society
IKDC: International Knee Documentation Committee
KOOS: Knee Injury and Osteoarthritis Outcome Score
OAT: osteochondral autograft transfer, i.e. mosaicplasty
OCD: osteochondral defect
MF: microfracture
SD: standard deviation
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Pearsall 2014 Not a randomised clinical trial. Patient allocation was based on health insurance conditions
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D A T A A N D A N A L Y S E S
Comparison 1. Mosaicplasty versus microfracture
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Function (all scores/instruments)
: intermediate term (1 to 5
years of follow-up)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 IKDC 2000 score 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Function (all scores/instruments)
: long term (5 or more years of
follow-up)
3 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 Lysholm score 2 72 Mean Difference (IV, Fixed, 95% CI) -1.10 [-4.54, 2.33]
2.2 IKDC 2000 score 1 57 Mean Difference (IV, Fixed, 95% CI) 13.97 [13.25, 14.69]
3 Quality of life: long-term (5 or
more years of follow-up)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
4 Failure of treatment and adverse
effects: long-term (5 or more
years of follow-up)
3 129 Risk Ratio (M-H, Fixed, 95% CI) 0.47 [0.24, 0.90]
5 Pain: long-term (5 or more years
of follow-up)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6 Activity (Tegner score; 1 to 10:
best score): intermediate term
(1 to 5 years follow-up)
1 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 3 years follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Activity (Tegner score; 1 to 10:
best score): long term (5 or
more years follow-up)
3 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7.1 Mean 10.4 years follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Mean 6.3 years follow-up 1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Median 9.8 years follow-
up
1 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Sports activity 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
8.1 Return to same level of
pre-injury sport activities
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Continuation of sports at
3 years
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Continuation of sports at
10 years
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Quality of cartilage at long-term
follow-up: magnetic resonance
image (satisfactory cartilage
characteristics)
2 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
9.1 Outerbridge 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 Mocart Score Degree of
defect repair and filling
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.3 Mocart Score Integration
to border zone
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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9.4 Mocart Score Surface of
the repair tissue
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.5 Mocart Score Structure of
the repair tissue
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.6 Mocart Score
Subchondral lamina
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.7 Mocart Score
Subchondral bone
1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.8 Mocart Score Adhesion 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.9 Mocart Score Effusion 1 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Quality of cartilage: “Second-
look” arthroscopy at around 1
year. Excellent and good
2 71 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.74, 2.21]
11 Quality of cartilage: presence of
hyaline cartilage in biopsy
1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
12 Quality of cartilage at long term
follow-up: signs of radiographic
osteoarthritis
2 80 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.25, 0.92]
A D D I T I O N A L T A B L E S
Table 1. Key baseline characteristics of the included trials
Study ID Number
with
baseline
data
Mean age in
years
Males (%) Sports Defect
grade
Defect
a area range
andmean in
cm2
Trauma ori-
gin (%)
Mean dura-
tion
of
symptoms
in months
Gudas 2005 57 24.4 36 (63) All athletes ICRS
3 or 4b
1.0 to 4.0b
mean 2.78
32 (56) 21.3
Lim 2012 51c 31.8 29 (57) ? Outerbridge
3 or 4b
1.0 to 4.0
mean 2.76
?d ?
Ulstein
2014
25 32.3 14 (56) All with Teg-
ner score < 6
b
ICRS
3 or 4b
2.0 to 6.0
mean 2.82
11 (44) 91.3
a all were single lesions
b inclusion criterion
c 52 knees
d isolated lesion, no other knee injuries
ICRS: International Cartilage Repair Society score
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
When trials included more than one measure of function, we chose the IKDC score (included in the ICRS cartilage injury evaluation
package but referred to as ICRS scores in Gudas 2005) and Lysholm score rather than HSS score and KOOS score. Lysholm is the
most commonly used in the literature and the KOOS score has five subgroups that are not recommended to be summed.
We included two subcategories of the KOOS score, quality of life (KOOSQOL) and KOOS pain, as primary and secondary outcomes.
We also included the categorisation of activity level from the ICRS ’Cartilage Injury Standard Evaluation Form’.
Our previously defined subgroup analyses were not performed because of lack of data. We introduced a modified subgroup analysis
(cartilage defect (chondral lesion) versus osteochondral defect (osteochondral lesion)). We opted to introduce this subgroup because
osteochondral lesions require treatment of not only the cartilage but the damaged bone (Gomoll 2010a). Surgical treatment options
such as mosaicplasty and allograft transplantation have the theoretical advantage of treating bone and cartilage defects at the same time
and could potentially present better clinical outcomes than microfracture and drilling. Based on that, some algorithms of treatment
available in the literature base their surgical decision on whether bone damage is present.
We decided to present a ’Summary of findings’ table in order to highlight the insufficiency of the data as well as to give a better view
of clinical relevance of the results. We selected for presentation all three primary outcomes, with pain and activity level assessed via the
Tegner score; for both function and activity levels, we presented separate results for intermediate- and long-term follow-up.
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